Phacilitate Leaders World


Vamil K  Divan

Vamil K Divan

Senior Research Analyst, Credit Suisse LLC

Vamil Divan, MD has worked in equity research at Credit Suisse since 2007 and is now the Senior Analyst covering the U.S. Pharmaceutical sector. From 2011-2013 he led the Life Science Tools and Diagnostics team and prior to that he was a member of the U.S. Pharmaceuticals team. Before joining Credit Suisse, Vamil worked in the pharmaceutical industry. He was an Associate Director at Roche in Drug Safety and Risk Management and then a Medical Director at Pfizer with a focus on commercial products in neuroscience and inflammation. Vamil holds an MD degree from the University of Buffalo, an MBA from New York University. He did his Internal Medicine residency at Mount Sinai Medical Center in New York City and then was a practicing physician prior to joining the pharmaceutical industry.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman